SEC Form 4 · accession 0001190725-16-000509
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce L A Carter
Director
Period of report
Sep 27, 2016
Accepted (ET)
Sep 29, 2016 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $6.78 | Sep 27, 2016 | A | 25,000 | A | — | Sep 26, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares subject to the Option vest and become exercisable in 36 equal monthly installments following the date of grant.